title: Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium.
abstract: The critical shortage of human donor organs has generated interest in the potential for porcine to human xenotransplantation. The initial immunological barrier to xenotransplantation is hyperacute rejection, which is mediated by xenoreactive antibodies and complement, and results in rapid and irreversible tissue destruction. While endogenous complement regulatory proteins (CRPs) protect cells from injury caused by autologous complement, they are relatively species specific and most likely ineffectual in this setting. This has led to the hypothesis that expression of human CRPs in transgenic pigs may affect susceptibility to complement-mediated tissue injury in a porcine-to-human xenograft. Using specific lines of transgenic pigs that express low levels of human CD59, a CRP that acts at the terminal stage of the complement cascade, we present evidence that shows that the human CD59 protein inhibits membrane attack complex assembly and reduces tissue damage when the heart is transplanted to a baboon. Examination by immunohistochemistry of transgenic porcine hearts after transplantation revealed markedly reduced deposition of C5b and MAC, but a similar level of C3 deposition as compared with transplanted control hearts. This finding supports the concept that the species specific function of CRPs contributes to the humoral barrier to xenotransplantation and, given the low level of human CD59 protein expression in the porcine heart, argues that the human protein contributes a unique rather than an additive function in regulation of complement in a xenogeneic setting.
authors.affiliation: Nextran, Princeton, NJ 08540, USA.
authors.forename: L E
authors.initials: LE
authors.lastname: Diamond
authors.forename: K R
authors.initials: KR
authors.lastname: McCurry
authors.forename: M J
authors.initials: MJ
authors.lastname: Martin
authors.forename: S B
authors.initials: SB
authors.lastname: McClellan
authors.forename: E R
authors.initials: ER
authors.lastname: Oldham
authors.forename: J L
authors.initials: JL
authors.lastname: Platt
authors.forename: J S
authors.initials: JS
authors.lastname: Logan
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D018957:CD59 Antigens / Q000096:biosynthesis* / Q000235:genetics; D003165:Complement System Proteins / Q000378:metabolism; D004727:Endothelium / Q000378:metabolism; D018014:Gene Transfer Techniques; D016027:Heart Transplantation; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D010215:Papio; D013552:Swine
chemical_list: D018957:CD59 Antigens; D003165:Complement System Proteins